2013
DOI: 10.5455/jcer.201314
|View full text |Cite
|
Sign up to set email alerts
|

Drug utilization study of HIV positive patients registered with antiretroviral therapy centre of a tertiary care hospital

Abstract: Objective: To determine the drug utilization pattern among HIV (Human Immunodeficiency Virus) outpatients in antiretroviral therapy (ART) centre of a tertiary care hospital. Method: We conducted a prospective, longitudinal follow up study of one year duration. Collected data was analyzed using descriptive statistics. Results: A total of 1491 prescriptions were collected from 250 HIV positive patients. Majority of the drugs were prescribed in oral dosage form. The average number of drugs per encounter was 4.26 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
23
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(26 citation statements)
references
References 14 publications
2
23
0
Order By: Relevance
“…In the present study, zidovudine+lamivudine+nevirapine (ZLN) (86.75%) were the most commonly prescribed HAART combination followed by tenofovir+lamivudine+ effavirenz (TLE) (36.42%) and stavudine+lamivudine+nevirapine (SLN) (34.44%). Similar results were found in Jiyo C et al and Oreagba A. et al 16,1 The most common regimen prescribed among the first line HAART was the combination of zidovudine+lamivudine+nevirapine (26.76%) followed by stavudine+lamivudine+nevirapine (10.53%). The above findings is in accordance with our national guidelines for antiretroviral therapy which recommends ZLN as the first choice and SLN as second choice among all first line HAART regimens.…”
Section: Resultssupporting
confidence: 78%
See 2 more Smart Citations
“…In the present study, zidovudine+lamivudine+nevirapine (ZLN) (86.75%) were the most commonly prescribed HAART combination followed by tenofovir+lamivudine+ effavirenz (TLE) (36.42%) and stavudine+lamivudine+nevirapine (SLN) (34.44%). Similar results were found in Jiyo C et al and Oreagba A. et al 16,1 The most common regimen prescribed among the first line HAART was the combination of zidovudine+lamivudine+nevirapine (26.76%) followed by stavudine+lamivudine+nevirapine (10.53%). The above findings is in accordance with our national guidelines for antiretroviral therapy which recommends ZLN as the first choice and SLN as second choice among all first line HAART regimens.…”
Section: Resultssupporting
confidence: 78%
“…Understanding HIV-TB co-infection is of great significance because of increasing prevalence, rapid progression of HIV disease in TB patients and challenges in treatment due to drug interactions and immune reconstitution syndrome. 16 …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The finding is in consonance with other studies. 6,12 Majority of patients (84.31%) were on non PI based regime. This finding is in accordance with other studies.…”
Section: Resultsmentioning
confidence: 99%
“…This finding is in accordance with other studies. 6,9 As per the ART guideline 2013 by NACO, PI-based regime is to be used as second line regime. 5 PI-based regimes can pose challenges, such as a more complex dosing schedules, drug interactions, toxicities and increase in cost.…”
Section: Resultsmentioning
confidence: 99%